Cooper Companies (NASDAQ:COO) Price Target Cut to $99.00 by Analysts at Needham & Company LLC

Cooper Companies (NASDAQ:COO) had its target price reduced by Needham & Company LLC from $100.00 to $99.00 in a research note released on Tuesday morning, MarketBeat Ratings reports. They currently have a buy rating on the medical device company’s stock.

COO has been the subject of a number of other research reports. William Blair raised Cooper Companies to a “strong-buy” rating in a research note on Friday, January 30th. Mizuho set a $100.00 target price on shares of Cooper Companies and gave the company an “outperform” rating in a research report on Friday, December 5th. Weiss Ratings upgraded shares of Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, January 12th. Stifel Nicolaus set a $95.00 target price on Cooper Companies and gave the stock a “buy” rating in a research note on Friday, December 5th. Finally, Robert W. Baird raised their target price on Cooper Companies from $85.00 to $98.00 and gave the stock an “outperform” rating in a research report on Friday, December 5th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $90.77.

Cooper Companies Stock Performance

COO opened at $79.33 on Tuesday. The firm has a market capitalization of $15.55 billion, a PE ratio of 42.20, a PEG ratio of 2.30 and a beta of 1.03. Cooper Companies has a 52-week low of $61.78 and a 52-week high of $97.21. The business’s 50-day simple moving average is $81.18 and its 200 day simple moving average is $74.36. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.13 and a current ratio of 1.89.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, December 4th. The medical device company reported $1.15 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.04. Cooper Companies had a net margin of 9.16% and a return on equity of 10.02%. The firm had revenue of $1.07 billion during the quarter, compared to analysts’ expectations of $1.06 billion. During the same quarter last year, the company posted $1.04 earnings per share. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. As a group, sell-side analysts expect that Cooper Companies will post 3.98 earnings per share for the current fiscal year.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, insider Holly R. Sheffield purchased 1,230 shares of Cooper Companies stock in a transaction that occurred on Tuesday, December 16th. The shares were bought at an average price of $80.75 per share, for a total transaction of $99,322.50. Following the acquisition, the insider directly owned 39,052 shares in the company, valued at approximately $3,153,449. This trade represents a 3.25% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Lawrence Erik Kurzius acquired 2,000 shares of the firm’s stock in a transaction on Wednesday, December 17th. The stock was bought at an average price of $82.50 per share, with a total value of $165,000.00. Following the completion of the acquisition, the director directly owned 7,777 shares in the company, valued at approximately $641,602.50. This represents a 34.62% increase in their position. The SEC filing for this purchase provides additional information. Over the last quarter, insiders bought 16,014 shares of company stock valued at $1,304,416. 1.98% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Cooper Companies

Several hedge funds have recently bought and sold shares of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Cooper Companies by 48.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock valued at $1,890,000 after acquiring an additional 7,363 shares in the last quarter. Robeco Institutional Asset Management B.V. lifted its position in shares of Cooper Companies by 9.8% in the second quarter. Robeco Institutional Asset Management B.V. now owns 17,686 shares of the medical device company’s stock valued at $1,259,000 after acquiring an additional 1,578 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. increased its holdings in Cooper Companies by 8.3% in the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 28,350 shares of the medical device company’s stock valued at $2,017,000 after acquiring an additional 2,161 shares during the last quarter. Hardy Reed LLC boosted its position in shares of Cooper Companies by 4.1% during the 2nd quarter. Hardy Reed LLC now owns 6,213 shares of the medical device company’s stock valued at $442,000 after acquiring an additional 244 shares during the last quarter. Finally, KLP Kapitalforvaltning AS grew its position in Cooper Companies by 1.9% in the second quarter. KLP Kapitalforvaltning AS now owns 69,500 shares of the medical device company’s stock worth $4,946,000 after acquiring an additional 1,300 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.